Epileptic Seizures
7
1
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Wearable Epileptic Seizure Prediction and Alert Glasses Based on Neuromorphic Computing
Status Epilepticus Population Study (STEPS)
Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy
Study to Validate Novel Seizure-Detection Algorithm
Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors
Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy
Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis